- Sciwind has two Western partners for its obesity drug, but is open to moreSciwind Biosciences has already licensed its GLP-1 obesity drug ecnoglutide twice over — to Pfizer and Verdiva Bio — but it is not done yet. The Chinese biotech is seeking new partners for the ri…Endpoints · 1mo ago↗ source
- The seeming inevitability of rising healthcare costsWe’re getting our first signs of where healthcare costs are heading next year. According to a survey of actuaries at 27 health plans covering employers and individuals on the exchangesEndpoints · 1mo ago↗ source
- Drugmakers are turning to logistics providers as trade disruptions linger, DHL exec saysDHL is in discussions with multiple major drugmakers who are looking for the logistics company to either take over their sites or access its resources, the company’s supply chain business CEO Hendr…